Synthesis and Enzymological Characterization of Some 2-(Substitutedphenylamino) quinazolin-4(3H)-one Derivatives as Potent α-Glucosidase Inhibitors In Vitro
Journal:
Letters in Drug Design & Discovery
Volume:
18
Page:
723-732
Author(s):
Emre Kadir Ayan, Zeynep Soyer* and Şirin Uysal
Sex Differences in Clinical Outcomes of Patients with Stable Coronary Artery Disease after Percutaneous Coronary Intervention
Journal:
Current Pharmaceutical Design
Volume:
27
Page:
3180-3185
Author(s):
Emmanuel P. Vardas, Evangelos Oikonomou, Gerasimos Siasos, Panagiotis Theofilis, Polychronis Dilaveris, Angelos Papanikolaou and Dimitris Tousoulis*
Gender Disparities on Access to Care and Coronary Disease Management
Journal:
Current Pharmaceutical Design
Volume:
27
Page:
3210-3220
Author(s):
Zorana Vasiljevic-Pokrajcic*, Gordana Krljanac, Ratko Lasica, Marija Zdravkovic, Sanja Stankovic, Predrag Mitrovic, Vladan Vukcevic and Milika Asanin
Sex Differences and Emerging New Risk Factors for Atherosclerosis and Its Thrombotic Complications
Journal:
Current Pharmaceutical Design
Volume:
27
Page:
3186-3197
Author(s):
Teresa Padro*, Natalia Muñoz-Garcia, Esther Peña and Lina Badimon
Pregnancy Complicated by the Most Frequent Forms of Maturity Onset Diabetes of the Young: A Narrative Review on Its Pharmacological Implications
Journal:
Current Reviews in Clinical and Experimental Pharmacology
Volume:
16
Page:
228-234
Author(s):
Claudio Daniel Gonzalez, Victoria Insussarry Perkins, Agustina Alves de Lima, Rocio Fogar, Gustavo D. Frechtel and Guillermo Di Girolamo*
Exosome Limitations in the Treatment of Inflammatory Diseases
Journal:
Current Pharmaceutical Design
Volume:
27
Page:
3105-3121
Author(s):
Daria Skuratovskaia*, Maria Vulf, Olga Khaziakhmatova, Vladimir Malashchenko, Aleksandra Komar, Egor Shunkin, Natalia Gazatova and Larisa Litvinova
Glycolytic Inhibition and Antidiabetic Activity on Synthesized Flavanone Scaffolds with Computer Aided Drug Designing Tools
Journal:
Letters in Drug Design & Discovery
Volume:
18
Page:
574-592
Author(s):
Natarajan Kiruthiga*, Govindaraj Saravanan*, Chellappa Selvinthanuja, Kulandaivel Srinivasan and Thangavel Sivakumar
Inflammatory Markers Associated With Diabetes Mellitus – Old and New Players
Journal:
Current Pharmaceutical Design
Volume:
27
Page:
3020-3035
Author(s):
Emir Muzurović*, Zoja Stanković, Zlata Kovačević, Benida Š. Škrijelj and Dimitri P. Mikhailidis
The Impetus of COVID -19 in Multiple Organ Affliction Apart from Respiratory Infection: Pathogenesis, Diagnostic Measures and Current Treatment Strategy
Journal:
Infectious Disorders - Drug Targets
Volume:
21
Page:
514-526
Author(s):
Bilha Baby, Aswathy R Devan, Bhagyalakshmi Nair and Lekshmi R. Nath*
COVID-19 and Type 2 Diabetes Mellitus: HCQ may be the Holy Grail
Journal:
Infectious Disorders - Drug Targets
Volume:
21
Page:
3-6
Author(s):
Rimesh Pal, Manoj K. Bhasin and Sanjay K. Bhadada*